Studies conducted by Guzman and colleagues demonstrated that PTL induced apoptosis in primary human AML cells, progenitor and LSCs by inhibiting the NF-κB pathway, activating p53, increasing reactive oxygen species (ROS) and JNK activation both in vitro and in vivo [132,133]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.